FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephanie Filleur

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Mouse
Rats

Anatomy

Physiology

Drug Resistance, Neoplasm

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Thomas Nelius; Christina Samathanam; Jessica Stevens; Werner de Riese; Natalie Gaines; Johnny Hickson; Dalia Martinez-Marin; Stephanie Filleur
Positive correlation between PEDF expression levels and macrophage density in the human prostate.
Brandon Trojan; Andrew Tang; Jason Chandrapal; Stephanie Filleur; Thomas Nelius
The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria.
Lyndon Bastatas; Stephanie Filleur; Jood Hashem; Yong J Lee; Dalia Martinez-Marin; Raul Martinez-Zaguilan; James Matthews; Souad Sennoune; Soyeun Park
AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephanie Filleur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Nelius; Christina Samathanam; Jessica Stevens; Werner de Riese; Natalie Gaines; Johnny Hickson; Dalia Martinez-Marin; Stephanie Filleur
Positive correlation between PEDF expression levels and macrophage density in the human prostate.
The Prostate 2013;73(5):549-61.
2013: Brandon Trojan; Andrew Tang; Jason Chandrapal; Stephanie Filleur; Thomas Nelius
The clinical usefulness of nuclear matrix protein-22 in patients with end-stage renal disease and microscopic hematuria.
Renal failure 2013;35(1):72-6.
2012: Lyndon Bastatas; Stephanie Filleur; Jood Hashem; Yong J Lee; Dalia Martinez-Marin; Raul Martinez-Zaguilan; James Matthews; Souad Sennoune; Soyeun Park
AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential.
Biochimica et biophysica acta 2012;1820(7):1111-20.
2011: Thomas Nelius; K Rinard; Stephanie Filleur
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature.
Cancer treatment reviews 2011;37(6):444-55.
2011: Jennifer Hirsch; Christina Lisa Johnson; Ronald Kennedy; Thomas Nelius; Werner de Riese; Stephanie Filleur
PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.
Cytokine 2011;55(2):202-10.
2011: J Nelson; K Rinard; Stephanie Filleur; A Haynes; Thomas Nelius
Extraluminal colonic carcinoma invading into kidney: a case report and review of the literature.
ISRN urology 2011;2011():707154.
2011: Thomas Nelius; K Rinard-Holden; J Vordermark; I Al-Khalil; T Cammack; V Mamlok; Stephanie Filleur
TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature.
Case reports in medicine 2011;2011():432917.
2010: Thomas Nelius; J Stevens; C Samathanam; Stephanie Filleur
Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.
Medical oncology (Northwood, London, England) 2010;27(2):562-7.
2010: Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur
Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.
Medical oncology (Northwood, London, England) 2010;27(2):363-7.
2010: Thomas Nelius; Stephanie Filleur
[Self-inflicted penile strangulation].
Aktuelle Urologie 2010;41(1):64-6.
2009: Thomas Nelius; Stephanie Filleur
PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy.
The Prostate 2009;69(16):1802-7.
2009: Stephanie Filleur; Thomas Nelius; W de Riese; Ronald C Kennedy
Characterization of PEDF: a multi-functional serpin family protein.
Journal of cellular biochemistry 2009;106(5):769-75.
2009: Stephanie Filleur; Jennifer Hirsch; Aline Wille; Margarete Schön; Christian Sell; Michael H Shearer; Thomas Nelius; Ilse Wieland
INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling.
Cancer cell international 2009;9():28.
2008: Norm D Smith; Frank Thilo Schulze-Hoepfner; Dorina Veliceasa; Stephanie Filleur; Sarah Shareef; Lijun Huang; Xue-Mei Huang; Olga V Volpert
Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.
The Journal of urology 2008;179(6):2427-34.
2008: Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur
Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
International urology and nephrology 2008;40(1):97-104.
2007: Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina V Budunova; Emelyn H Shroff; Yelena Mirochnik; Arin B. Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.
International journal of cancer. Journal international du cancer 2007;121(5):999-1008.
2007: Tobias Klatte; Malte Böhm; Thomas Nelius; Stephanie Filleur; Frank Reiher; Ernst Peter Allhoff
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma.
BJU international 2007;100(1):209-14.
2006: Thomas Nelius; Tobias Klatte; Ron Yap; Thomas Kalinski; Albrecht Röpke; Stephanie Filleur; Ernst Peter Allhoff
A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer.
BJU international 2006;98(3):580-5.
2006: Thomas Nelius; Frank Reiher; T Lindenmeir; Thomas Kalinski; Olrik Rau; Stephanie Filleur; Ernst Peter Allhoff
[Idiopathic retroperitoneal fibrosis (Ormond's disease)].
Aktuelle Urologie 2006;37(4):284-8.
2005: Thomas Nelius; Frank Reiher; Tobias Lindenmeir; Tobias Klatte; Olrik Rau; Jens Burandt; Stephanie Filleur; Ernst Peter Allhoff
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.
Onkologie 2005;28(11):573-8.
2005: Aurélie Fontana; Stephanie Filleur; Julien Guglielmi; Lucien Frappart; Gabriella Bruno-Bossio; Sandrine Boissier; Florence Cabon; Philippe Clézardin
Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo.
International journal of cancer. Journal international du cancer 2005;116(5):686-91.
2005: Stephanie Filleur; Karl Volz; Thomas Nelius; Yelena Mirochnik; Hanhua Huang; Tetiana Zaichuk; Maria S Aymerich; S Patricia Becerra; Ronald L Yap; Dorina Veliceasa; Emelyn H Shroff; Olga V Volpert
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
Cancer research 2005;65(12):5144-52.
2005: Antonio Jesús Quesada; Thomas Nelius; Ronald L Yap; Tetiana Zaichuk; Arántzazu Alfranca; Stephanie Filleur; Olga V Volpert; Juan Miguel Redondo
In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.
Cell death and differentiation 2005;12(6):649-58.
2005: Marc Colombel; Stephanie Filleur; Pierrick Fournier; Carole Merle; Julien Guglielmi; Aurélie Courtin; Armelle Degeorges; Claire-Marie Serre; Raymonde Bouvier; Philippe Clézardin; Florence Cabon
Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Cancer research 2005;65(1):300-8.
2004: Tetiana Zaichuk; Emelyn H Shroff; Rebekah Emmanuel; Stephanie Filleur; Thomas Nelius; Olga V Volpert
Nuclear factor of activated T cells balances angiogenesis activation and inhibition.
The Journal of experimental medicine 2004;199(11):1513-22.
2003: Stephanie Filleur; Aurélie Courtin; SLIMANE AIT-SI-ALI; Julien Guglielmi; Carole Merle; Annick Harel-Bellan; Philippe Clézardin; Florence Cabon
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Cancer research 2003;63(14):3919-22.
2002: Pierrick Fournier; Sandrine Boissier; Stephanie Filleur; Julien Guglielmi; Florence Cabon; Marc Colombel; Philippe Clézardin
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Cancer research 2002;62(22):6538-44.
2001: Stephanie Filleur; Olga V Volpert; Armelle Degeorges; Carole Voland; Frank Reiher; Philippe Clézardin; Noel P Bouck; Florence Cabon
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Genes & development 2001;15(11):1373-82.
2000: Slimane Ait-Si-Ali; Anna Polesskaya; Stephanie Filleur; R Ferreira; Arnaud Duquet; SLIMANE AIT-SI-ALI; A Vervish; Didier Trouche; Florence Cabon; Annick Harel-Bellan
CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.
Oncogene 2000;19(20):2430-7.
1999: V Dejong; Armelle Degeorges; Stephanie Filleur; SLIMANE AIT-SI-ALI; A Mettouchi; P Bornstein; Bernard Binétruy; Florence Cabon
The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
Oncogene 1999;18(20):3143-51.